At IPS, we’re proud to support the world’s most innovative companies find a solution to end the COVID-19 pandemic. The industry knows us for our expertise, and clients know us for our commitment to succeed. We’re proud to earn their respect; we’re proud to earn their trust.
Our employees are working at warp speed with the supply chain to design, build, validate these critical facilities. We are doing our part to get vaccines and therapies to those who need it most.
We are Proud to Be Part of the Solution
As the world tackles the pandemic and tries to create a sense of normalcy during these unprecedented times, we at IPS continue to work in excellence with our clients to deliver fast-track solutions to the pandemic. The industry knows us for our expertise, and clients know us for our commitment to succeed. We’re proud to earn their respect; we’re proud to earn their trust.
We support our clients around the globe and work on projects that utilize a wide spectrum of our subject matter experts, technical disciplines, technologies, and tools. We offer clients a single source, integrated approach to designing, constructing, and validating technically complex facilities that span across industries and facility types:
Our staff has been working around the clock on many COVID-related projects, at various stages of their project life cycle. We are all committed to offering solutions to help fight the coronavirus and bring the necessary vaccines and therapeutics to commercial production. Below are some sample projects we are currently supporting:
- Renovating a development laboratory and delivering a clinical facility for vaccines manufacturer.
- Designing and building a sterile manufacturing facility for a biopharmaceutical company’s COVID-19 vaccine, under the direction of the US government’s Biomedical Advanced Research and Development Authority (BARDA) department. We are also expediting the construction of a separate fill-finish facility for vaccine filling operations.
- Providing engineering services for a large-scale freezer farm to store a leading pharmaceutical company’s vaccine product. In addition to the freezer farm, we are also providing support for the vaccine formulation and filling.
- Providing an EPCMV integrated approach to an international pharmaceutical company’s vaccine filling facility.
- Developing a project concept based on a hybrid turnkey delivery model for a contract manufacturer’s production of a well-known biopharmaceutical company.
- Converting an existing manufacturing facility for a global manufacturing client to produce new COVID-related therapeutic.
- Fast-tracking the production and delivery of a novel COVID-related therapeutic to begin clinical trials soon.
